Doctors and ministers oppose EC’s plans for testing IVF samplesBMJ 2009; 339 doi: https://doi.org/10.1136/bmj.b5016 (Published 24 November 2009) Cite this as: BMJ 2009;339:b5016
- Rory Watson
The European Commission’s plan to insist that reproductive cells being processed or stored for treatments such as in vitro fertilisation (IVF) should be tested for a number of infections to avoid possible cross-contamination is being strongly resisted by national governments and the medical profession.
The European Society of Human Reproduction and Embryology maintains that the new requirement is unnecessary and would have substantial implications for the cost of fertility treatment in Europe.
“With 900 000 assisted reproduction treatments annually, such as IVF and intrauterine inseminations, in Europe, the European Commission’s proposal to screen both partners before each treatment could …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial